In osteosarcoma, NGF protein is elevated and correlates with stage, while NGF–MEK/ERK signaling drives MMP−2–linked motility; these observations justify inclusion of NGF, phospho−ERK, and MMP−2 as core readouts and support composite activity scores integrating receptor phosphorylation with protease expression (51–53). This evidence concerns the gene NGF and osteosarcoma.